Inactive Instrument
GW Pharmaceuticals plc Stock London S.E.
Stocks
GB0030544687
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Alkesh Patel
SEC | Corporate Secretary | - | 2024-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
David Spackman
BRD | Director/Board Member | 50 | 2023-01-12 |
Amanda Flanagan
BRD | Director/Board Member | 55 | 2025-02-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.17% | -4.39% | +45.51% | +79.00% | 52.1B | |
| +0.24% | -1.54% | +53.22% | +71.85% | 53.83B | |
| +0.80% | -6.31% | +3.98% | +423.29% | 23.48B | |
| -0.09% | -0.01% | -17.62% | -14.67% | 23.13B | |
| -5.95% | -2.58% | +30.67% | -9.58% | 19.36B | |
| -1.14% | +0.03% | +31.57% | -30.42% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +306.37% | 15.2B | |
| -6.91% | -5.83% | +26.53% | +636.97% | 14.83B | |
| +0.43% | -1.03% | +24.63% | +191.40% | 14.06B | |
| Average | -2.77% | -2.62% | +40.77% | +183.80% | 25.95B | |
| Weighted average by Cap. | -2.80% | -2.36% | +40.12% | +144.11% |
Employees
-
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
